Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Erratum: Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity.

Douglass JD, Zhou YX, Wu A, Zadroga JA, Gajda AM, Lackey AI, Lang W, Chevalier KM, Sutton SW, Zhang SP, Flores CM, Connelly MA, Storch J.

J Lipid Res. 2019 Mar;60(3):717. doi: 10.1194/jlr.M058586ERR. No abstract available.

2.

Evolution of membrane oxygenator technology for utilization during pediatric cardiopulmonary bypass.

Melchior RW, Sutton SW, Harris W, Dalton HJ.

Pediatric Health Med Ther. 2016 Jun 28;7:45-56. doi: 10.2147/PHMT.S35070. eCollection 2016. Review.

3.

Brain α7 Nicotinic Acetylcholine Receptor Assembly Requires NACHO.

Gu S, Matta JA, Lord B, Harrington AW, Sutton SW, Davini WB, Bredt DS.

Neuron. 2016 Mar 2;89(5):948-55. doi: 10.1016/j.neuron.2016.01.018. Epub 2016 Feb 11.

4.

GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids L-Tryptophan and L-Phenylalanine.

Liu C, Bonaventure P, Lee G, Nepomuceno D, Kuei C, Wu J, Li Q, Joseph V, Sutton SW, Eckert W, Yao X, Yieh L, Dvorak C, Carruthers N, Coate H, Yun S, Dugovic C, Harrington A, Lovenberg TW.

Mol Pharmacol. 2015 Nov;88(5):911-25. doi: 10.1124/mol.115.100412. Epub 2015 Sep 8.

PMID:
26349500
5.

Global deletion of MGL in mice delays lipid absorption and alters energy homeostasis and diet-induced obesity.

Douglass JD, Zhou YX, Wu A, Zadroga JA, Gajda AM, Lackey AI, Lang W, Chevalier KM, Sutton SW, Zhang SP, Flores CM, Connelly MA, Storch J.

J Lipid Res. 2015 Jun;56(6):1153-71. doi: 10.1194/jlr.M058586. Epub 2015 Apr 4. Erratum in: J Lipid Res. 2019 Mar;60(3):717.

7.

Relaxin-3 receptor (Rxfp3) gene knockout mice display reduced running wheel activity: implications for role of relaxin-3/RXFP3 signalling in sustained arousal.

Hosken IT, Sutton SW, Smith CM, Gundlach AL.

Behav Brain Res. 2015 Feb 1;278:167-75. doi: 10.1016/j.bbr.2014.09.028. Epub 2014 Sep 22.

PMID:
25257104
8.

Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation.

Soroosh P, Wu J, Xue X, Song J, Sutton SW, Sablad M, Yu J, Nelen MI, Liu X, Castro G, Luna R, Crawford S, Banie H, Dandridge RA, Deng X, Bittner A, Kuei C, Tootoonchi M, Rozenkrants N, Herman K, Gao J, Yang XV, Sachen K, Ngo K, Fung-Leung WP, Nguyen S, de Leon-Tabaldo A, Blevitt J, Zhang Y, Cummings MD, Rao T, Mani NS, Liu C, McKinnon M, Milla ME, Fourie AM, Sun S.

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12163-8. doi: 10.1073/pnas.1322807111. Epub 2014 Aug 4.

9.

Involvement of β-arrestin-2 and clathrin in agonist-mediated internalization of the human cannabinoid CB2 receptor.

Chen X, Zheng C, Qian J, Sutton SW, Wang Z, Lv J, Liu C, Zhou N.

Curr Mol Pharmacol. 2014;7(1):67-80.

PMID:
25023974
10.

Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (μ-TRTX-Hh2a).

Minassian NA, Gibbs A, Shih AY, Liu Y, Neff RA, Sutton SW, Mirzadegan T, Connor J, Fellows R, Husovsky M, Nelson S, Hunter MJ, Flinspach M, Wickenden AD.

J Biol Chem. 2013 Aug 2;288(31):22707-20. doi: 10.1074/jbc.M113.461392. Epub 2013 Jun 12.

11.

Identification of Hydroxybenzoic Acids as Selective Lactate Receptor (GPR81) Agonists with Antilipolytic Effects.

Dvorak CA, Liu C, Shelton J, Kuei C, Sutton SW, Lovenberg TW, Carruthers NI.

ACS Med Chem Lett. 2012 Jun 11;3(8):637-9. doi: 10.1021/ml3000676. eCollection 2012 Aug 9.

12.

In vitro pharmacological characterization of RXFP3 allosterism: an example of probe dependency.

Alvarez-Jaimes L, Sutton SW, Nepomuceno D, Motley ST, Cik M, Stocking E, Shoblock J, Bonaventure P.

PLoS One. 2012;7(2):e30792. doi: 10.1371/journal.pone.0030792. Epub 2012 Feb 7.

13.

A tribute to John Capehart, MD, "Sooner proud" and 1961 National Spelling Bee champion.

Sutton SW, Guillen MA, Hebeler RF, Hamman BL.

Proc (Bayl Univ Med Cent). 2011 Oct;24(4):343-5. No abstract available.

14.

Relaxin-3 null mutation mice display a circadian hypoactivity phenotype.

Smith CM, Hosken IT, Sutton SW, Lawrence AJ, Gundlach AL.

Genes Brain Behav. 2012 Feb;11(1):94-104. doi: 10.1111/j.1601-183X.2011.00730.x. Epub 2011 Oct 19.

15.

Oxysterols direct B-cell migration through EBI2.

Liu C, Yang XV, Wu J, Kuei C, Mani NS, Zhang L, Yu J, Sutton SW, Qin N, Banie H, Karlsson L, Sun S, Lovenberg TW.

Nature. 2011 Jul 27;475(7357):519-23. doi: 10.1038/nature10226.

PMID:
21796211
16.

Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists.

Tran DT, Bonaventure P, Hack M, Mirzadegan T, Dvorak C, Letavic M, Carruthers N, Lovenberg T, Sutton SW.

Eur J Pharmacol. 2011 Sep 30;667(1-3):120-8. doi: 10.1016/j.ejphar.2011.05.074. Epub 2011 Jun 12.

PMID:
21679703
17.

Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain.

Smith CM, Shen PJ, Banerjee A, Bonaventure P, Ma S, Bathgate RA, Sutton SW, Gundlach AL.

J Comp Neurol. 2010 Oct 1;518(19):4016-45. doi: 10.1002/cne.22442.

PMID:
20737598
18.

Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex.

Si W, Aluisio L, Okamura N, Clark SD, Fraser I, Sutton SW, Bonaventure P, Reinscheid RK.

J Neurochem. 2010 Oct;115(2):475-82. doi: 10.1111/j.1471-4159.2010.06947.x. Epub 2010 Aug 30.

19.

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor.

Shoblock JR, Welty N, Nepomuceno D, Lord B, Aluisio L, Fraser I, Motley ST, Sutton SW, Morton K, Galici R, Atack JR, Dvorak L, Swanson DM, Carruthers NI, Dvorak C, Lovenberg TW, Bonaventure P.

Psychopharmacology (Berl). 2010 Feb;208(2):265-77. doi: 10.1007/s00213-009-1726-x. Epub 2009 Dec 2.

PMID:
19953226
20.

Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus.

Ma S, Olucha-Bordonau FE, Hossain MA, Lin F, Kuei C, Liu C, Wade JD, Sutton SW, Nuñez A, Gundlach AL.

Learn Mem. 2009 Oct 30;16(11):730-42. doi: 10.1101/lm.1438109. Print 2009 Nov.

PMID:
19880588
21.

Verification of a relaxin-3 knockout/LacZ reporter mouse as a model of relaxin-3 deficiency.

Smith CM, Shen PJ, Ma S, Sutton SW, Gundlach AL.

Ann N Y Acad Sci. 2009 Apr;1160:259-60. doi: 10.1111/j.1749-6632.2009.03952.x.

PMID:
19416199
22.

Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system.

Sutton SW, Shelton J, Smith C, Williams J, Yun S, Motley T, Kuei C, Bonaventure P, Gundlach A, Liu C, Lovenberg T.

Ann N Y Acad Sci. 2009 Apr;1160:242-9. doi: 10.1111/j.1749-6632.2008.03812.x.

PMID:
19416196
23.

Behavioral phenotyping of mixed background (129S5:B6) relaxin-3 knockout mice.

Smith CM, Lawrence AJ, Sutton SW, Gundlach AL.

Ann N Y Acad Sci. 2009 Apr;1160:236-41. doi: 10.1111/j.1749-6632.2009.03953.x.

PMID:
19416195
24.

Relaxin family peptides and receptors in mammalian brain.

Gundlach AL, Ma S, Sang Q, Shen PJ, Piccenna L, Sedaghat K, Smith CM, Bathgate RA, Lawrence AJ, Tregear GW, Wade JD, Finkelstein DI, Bonaventure P, Liu C, Lovenberg TW, Sutton SW.

Ann N Y Acad Sci. 2009 Apr;1160:226-35. doi: 10.1111/j.1749-6632.2009.03956.x. Review.

PMID:
19416194
25.

Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat.

Dugovic C, Shelton JE, Aluisio LE, Fraser IC, Jiang X, Sutton SW, Bonaventure P, Yun S, Li X, Lord B, Dvorak CA, Carruthers NI, Lovenberg TW.

J Pharmacol Exp Ther. 2009 Jul;330(1):142-51. doi: 10.1124/jpet.109.152009. Epub 2009 Apr 10.

PMID:
19363060
26.

Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81.

Liu C, Wu J, Zhu J, Kuei C, Yu J, Shelton J, Sutton SW, Li X, Yun SJ, Mirzadegan T, Mazur C, Kamme F, Lovenberg TW.

J Biol Chem. 2009 Jan 30;284(5):2811-22. doi: 10.1074/jbc.M806409200. Epub 2008 Dec 1.

27.

2-Aryloxymethylmorpholine histamine H(3) antagonists.

Letavic MA, Keith JM, Ly KS, Bonaventure P, Feinstein MA, Lord B, Miller KL, Motley ST, Nepomuceno D, Sutton SW, Carruthers NI.

Bioorg Med Chem Lett. 2008 Nov 1;18(21):5796-9. doi: 10.1016/j.bmcl.2008.09.077. Epub 2008 Sep 24.

PMID:
18922693
28.

Relaxin family peptide receptors--from orphans to therapeutic targets.

van der Westhuizen ET, Halls ML, Samuel CS, Bathgate RA, Unemori EN, Sutton SW, Summers RJ.

Drug Discov Today. 2008 Aug;13(15-16):640-51. doi: 10.1016/j.drudis.2008.04.002. Epub 2008 Jun 6. Review.

PMID:
18675759
30.

Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat.

Ma S, Bonaventure P, Ferraro T, Shen PJ, Burazin TC, Bathgate RA, Liu C, Tregear GW, Sutton SW, Gundlach AL.

Neuroscience. 2007 Jan 5;144(1):165-90. Epub 2006 Oct 30.

PMID:
17071007
31.

G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.

Sutton SW, Bonaventure P, Kuei C, Nepomuceno D, Wu J, Zhu J, Lovenberg TW, Liu C.

Neuroendocrinology. 2005;82(3-4):139-50. Epub 2006 Jan 13.

PMID:
16679775
32.

Cardiopulmonary bypass and mitral valve replacement during pregnancy.

Sutton SW, Duncan MA, Chase VA, Marce RJ, Meyers TP, Wood RE.

Perfusion. 2005 Oct;20(6):359-68. Review.

PMID:
16363322
33.

Intraperitoneal hyperthermic chemotherapy: experience at Baylor University Medical Center.

Kuhn JA, McLoughlin JM, Harris DC, Talaasen LJ, Sutton SW, McCarty TM.

Proc (Bayl Univ Med Cent). 2002 Oct;15(4):359-62.

34.

Recent progress in relaxin-3-related research.

Liu C, Bonaventure P, Sutton SW, Chen J, Kuei C, Nepomuceno D, Lovenberg TW.

Ann N Y Acad Sci. 2005 May;1041:47-60. Review.

PMID:
15956687
35.

Clinical benefits of continuous leukocyte filtration during cardiopulmonary bypass in patients undergoing valvular repair or replacement.

Sutton SW, Patel AN, Chase VA, Schmidt LA, Hunley EK, Yancey LW, Hebeler RF, Cheung EH, Henry AC 3rd, Meyers TP, Wood RE.

Perfusion. 2005 Jan;20(1):21-9. Erratum in: Perfusion. 2005 May;20(3):183.

PMID:
15751667
36.

Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing.

Sutton SW, Bonaventure P, Kuei C, Roland B, Chen J, Nepomuceno D, Lovenberg TW, Liu C.

Neuroendocrinology. 2004;80(5):298-307. Epub 2005 Jan 26.

PMID:
15677880
37.

Leukocyte filtration and miniature perfusion during arrested heart CABG on a Jehovah's Witness patient.

Sutton SW, Duncan MA, Chase VA, Cheung EH, Hamman BL.

Perfusion. 2004 Nov;19(6):375-9.

PMID:
15619972
38.
39.

A lab test and algorithms for identifying clients at risk for treatment failure.

Hannan C, Lambert MJ, Harmon C, Nielsen SL, Smart DW, Shimokawa K, Sutton SW.

J Clin Psychol. 2005 Feb;61(2):155-63.

PMID:
15609357
40.

Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian species.

Chen J, Kuei C, Sutton SW, Bonaventure P, Nepomuceno D, Eriste E, Sillard R, Lovenberg TW, Liu C.

J Pharmacol Exp Ther. 2005 Jan;312(1):83-95. Epub 2004 Sep 14.

PMID:
15367576
41.

Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists.

McAtee LC, Sutton SW, Rudolph DA, Li X, Aluisio LE, Phuong VK, Dvorak CA, Lovenberg TW, Carruthers NI, Jones TK.

Bioorg Med Chem Lett. 2004 Aug 16;14(16):4225-9.

PMID:
15261275
42.

Clinical benefits of leukocyte filtration during valve surgery.

Patel AN, Sutton SW, Livingston S, Patel A, Hunley EK, Hebeler RF, Henry AC 3rd, Hamman BL, Wood RE, Urschel HC Jr.

Am J Surg. 2003 Dec;186(6):636-9; discussion 639-40.

PMID:
14672771
43.

Intraoperative modality of treatment for peritoneal carcinomatosis: use of hyperthermic interperitoneal chemoperfusion.

Sutton SW, Yancey LW, Chase VA, Hunley EK, McCarty TM, Kuhn JA, Loggie BW.

Perfusion. 2002 Nov;17(6):441-6.

PMID:
12470035
45.

Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery.

Roland BL, Sutton SW, Wilson SJ, Luo L, Pyati J, Huvar R, Erlander MG, Lovenberg TW.

Endocrinology. 1999 Dec;140(12):5736-45.

PMID:
10579339
46.

Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.

Perrin MH, Sutton SW, Cervini LA, Rivier JE, Vale WW.

J Pharmacol Exp Ther. 1999 Feb;288(2):729-34.

PMID:
9918582
47.

Cloning and characterization of human urocortin.

Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW.

Endocrinology. 1996 Sep;137(9):3896. No abstract available.

PMID:
8756563
48.

Cloning and characterization of human urocortin.

Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW.

Endocrinology. 1996 May;137(5):2167-70. Erratum in: Endocrinology. 1996 Sep;137(9):3896.

PMID:
8612563
49.

Ligand requirements of the human corticotropin-releasing factor-binding protein.

Sutton SW, Behan DP, Lahrichi SL, Kaiser R, Corrigan A, Lowry P, Potter E, Perrin MH, Rivier J, Vale WW.

Endocrinology. 1995 Mar;136(3):1097-102.

PMID:
7867564
50.

Central activin administration modulates corticotropin-releasing hormone and adrenocorticotropin secretion.

Plotsky PM, Kjaer A, Sutton SW, Sawchenko PE, Vale W.

Endocrinology. 1991 May;128(5):2520-5.

PMID:
1850353

Supplemental Content

Loading ...
Support Center